Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether galectin-3 is associated with thrombogenicity in COVID-1...

Full description

Bibliographic Details
Main Authors: Marianna Puccini, Kai Jakobs, Leander Reinshagen, Julian Friebel, Philipp-Alexander Schencke, Emily Ghanbari, Ulf Landmesser, Arash Haghikia, Nicolle Kränkel, Ursula Rauch
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
galectin-3
increased thrombogenicity
platelet activation
COVID-19
Online Access:https://www.mdpi.com/1422-0067/24/9/7683

Internet

https://www.mdpi.com/1422-0067/24/9/7683

Similar Items